DNLI has had a good run in the past year on positive pipeline updates. A potential approval of its Hunter Syndrome drug should be a boost. However, recent pipeline setbacks warrant caution.

Authenticated data presented in the NIR and Raman Spectroscopy market report is based on findings of extensive primary and secondary research.

After hours: January 22 at 5:36:29 PM EST Loading Chart for JBSS ...

What is Cushing's syndrome? Cushing's syndrome is a hormonal disorder. It’s caused when you have high levels of the hormone cortisol over a long time. Cushing's syndrome is fairly rare. It most often ...